US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist
  • 12.242
  • -0.018-0.15%
Trading Apr 28 11:44 ET
177.22MMarket Cap0.11P/E (TTM)

About Inhibrx Biosciences Company

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded on January 8, 2024 and is headquartered in La Jolla, CA.

Company Profile

SymbolINBX
Company NameInhibrx Biosciences
Listing DateMay 29, 2024
Founded2024
CEOMr. Mark Paul Lappe
MarketNASDAQ
Employees161
Fiscal Year Ends12-31
Address11025 North Torrey Pines Road,Suite 140
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-795-4220
Websitehttp://www.inhibrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Mark Paul Lappe
  • Chief Executive Officer and Chairman of the Board
  • 4.69M
  • David J. Matly, M.B.A.
  • President, Chief Commercial Officer and Chief Business Development Officer
  • --
  • Kelly D. Deck, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 4.27M
  • Kimberly J. Manhard
  • Independent Director
  • 380.46K
  • Douglas G. Forsyth
  • Independent Director
  • 394.71K
  • Dr. Kristiina Vuori, M.D.,PhD
  • Independent Director
  • 382.34K
  • Dr. Jon Faiz Kayyem, PhD
  • Independent Director
  • 386.84K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 3.050
Sample Name
Sample Code
 8.690
Sample Name
Sample Code
 5.720
4
Hutchmed (China)
HCM
15.070
5
Constellation Brands
STZ
186.720
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 138.645
Sample Name
Sample Code
 9.510
Sample Name
Sample Code
 367.600
4
Toll Brothers
TOL
100.040
5
KB Home
KBH
53.550
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 138.570
Sample Name
Sample Code
 56.730
Sample Name
Sample Code
 367.530
4
Disney
DIS
90.140
5
Apple
AAPL
207.795
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1637
Sample Name
Sample Code
 2.010
Sample Name
Sample Code
 0.6399
4
Argo Blockchain
ARBK
0.4050
5
FRMO CORP
FRMO
8.530
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -